SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-011360
Filing Date
2024-03-26
Accepted
2024-03-26 17:28:40
Documents
15
Period of Report
2024-03-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 60601
2 ex10-1.htm EX-10.1 13792
3 ex10-2.htm EX-10.2 272077
  Complete submission text file 0001493152-24-011360.txt   577611

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE mgrx-20240325.xsd EX-101.SCH 3033
5 XBRL LABEL FILE mgrx-20240325_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE mgrx-20240325_pre.xml EX-101.PRE 22371
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3736
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

IRS No.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 24784841
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)